Edwards Lifesciences (EW) SVP Andrew Dahl Shares Withheld for Taxes

What Happened Andrew M. Dahl, Senior Vice President & Corporate Controller of Edwards Lifesciences (EW), had 253 shares withheld by the company to satisfy tax withholding obligations tied to the vesting of securities. The shares were valued at $84.37 each, for a total value of approximately $21,346. This was a tax-withholding action (not an open-market sale or purchase).

Key Details

• Transaction date: 2026-09-13; filing date (Form 4): 2026-09-14 (filed promptly).
• 253 shares withheld at $84.37 per share — total value ≈ $21,346.
• Transaction code: F (tax withholding incident to vesting).
• Footnote: Shares were withheld by the issuer to satisfy tax withholding per Rule 16b-3(e).
• Shares owned after the transaction: not disclosed in this filing (the Form 4 notes it reflects changes in beneficial ownership only).

Context

• This was a routine tax-withholding/cashless settlement of vested shares, not an open-market sale or purchase; such withholdings are common and generally administrative in nature.
• The filing does not indicate insider intent or broader portfolio changes.